Tango Therapeutics Inc Financial Flexibility Index
Tango Therapeutics Inc financial flexibility index. Tango Therapeutics Inc (TNGX) has a Financial Flexibility Index of -0.79x as of June 2026. Free cash flow of $-38.87 Million (operating CF $-38.87 Million minus capex $0.00) represents -1% of total liabilities ($49.35 Million). See Tango Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tango Therapeutics Inc (2019–2025)
Financial flexibility index of Tango Therapeutics Inc from 2019 to 2025. Historical Financial Flexibility Index trend for Tango Therapeutics Inc across 7 annual periods. Check Tango Therapeutics Inc (TNGX) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Tango Therapeutics Inc Financial Flexibility Index by Year (2019–2025)
Tango Therapeutics Inc financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Tango Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Tango Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.62x | $-137.84 Million | $-138.89 Million | $52.51 Million | ▼ -134.8% |
| 2024 | -1.12x | $-130.75 Million | $-131.50 Million | $116.97 Million | ▼ -43.4% |
| 2023 | -0.78x | $-116.46 Million | $-117.98 Million | $149.46 Million | ▼ -43.7% |
| 2022 | -0.54x | $-101.39 Million | $-109.08 Million | $186.99 Million | ▼ -46.1% |
| 2021 | -0.37x | $-57.69 Million | $-59.53 Million | $155.41 Million | ▼ -188.0% |
| 2020 | 0.42x | $71.18 Million | $70.07 Million | $168.65 Million | ▲ +187.9% |
| 2019 | -0.48x | $-22.99 Million | $-24.80 Million | $47.86 Million | — |